GUIDED THERAPEUTICS INC financial data

Symbol
GTHP on OTC
Location
Peachtree Corners, GA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 15% % -32%
Quick Ratio 10% % -15%
Debt-to-equity -120% % 9.5%
Return On Equity 49% %
Return On Assets -249% % -102%
Operating Margin -1233% % 77%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83,599,156 shares 37%
Common Stock, Shares, Outstanding 83,599 shares
Entity Public Float $3,717,645 USD -68%
Common Stock, Value, Issued $3,469,000 USD 0.67%
Weighted Average Number of Shares Outstanding, Basic 57,039 shares 11%
Weighted Average Number of Shares Outstanding, Diluted 68,291 shares 25%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $178,000 USD 368%
Research and Development Expense $482,000 USD 1.9%
Selling and Marketing Expense $215,000 USD -24%
General and Administrative Expense $1,610,000 USD 22%
Operating Income (Loss) $2,195,000 USD -6.5%
Nonoperating Income (Expense) $273,000 USD -435%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $2,632,000 USD -22%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $2,607,025 USD -49%
Earnings Per Share, Basic 0 USD/shares -25%
Earnings Per Share, Diluted 0 USD/shares -25%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $6,000 USD 200%
Inventory, Net $583,000 USD -8.3%
Other Assets, Current $123,000 USD -42%
Assets, Current $799,000 USD -23%
Property, Plant and Equipment, Net $18,000 USD -28%
Operating Lease, Right-of-Use Asset $69,000 USD -58%
Other Assets, Noncurrent $17,000 USD 0%
Assets $903,000 USD -28%
Accounts Payable, Current $2,382,000 USD 13%
Accrued Liabilities, Current $952,000 USD 3.1%
Liabilities, Current $6,470,000 USD 7.4%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $6,549,000 USD 6.2%
Retained Earnings (Accumulated Deficit) $155,813,000 USD -1.8%
Stockholders' Equity Attributable to Parent $5,646,000 USD -15%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $5,700,000 USD
Liabilities and Equity $903,000 USD -28%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $331,000 USD -231%
Net Cash Provided by (Used in) Financing Activities $58,000 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 83,599 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $273,000 USD -87%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $87,000 USD -55%
Interest Paid, Excluding Capitalized Interest, Operating Activities $20,000 USD 67%
Deferred Tax Assets, Valuation Allowance $17,565,000 USD -2.2%
Deferred Tax Assets, Gross $17,565,000 USD -2.2%
Operating Lease, Liability $76,000 USD -57%
Depreciation $2,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid $80,000 USD -59%
Property, Plant and Equipment, Gross $1,616,000 USD 0.12%
Operating Lease, Liability, Current $76,000 USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year Two $50,000 USD 79%
Lessee, Operating Lease, Liability, to be Paid, Year One $50,000 USD -58%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4,000 USD -79%
Deferred Tax Assets, Operating Loss Carryforwards $15,965,000 USD -2.6%
Additional Paid in Capital $145,212,000 USD 2.4%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $14,837 USD -86%
Interest Expense $567,000 USD 78%